Human Papillomavirus Burden in Different Cancers in Iran: a Systematic Assessment

被引:31
|
作者
Jalilvand, Somayeh [1 ]
Shoja, Zabihollah [2 ]
Hamkar, Rasool [1 ]
机构
[1] Univ Tehran Med Sci, Sch Publ Hlth, Dept Virol, Tehran, Iran
[2] Pasteur Inst Iran, Tehran, Iran
关键词
Human papillomaviruses; prevalence; HPV types; cancer types; Iran; SQUAMOUS-CELL CARCINOMA; RISK HUMAN-PAPILLOMAVIRUS; LUNG-CANCER; CERVICAL-CANCER; HPV INFECTIONS; PAP-SMEAR; TP53; GENE; PREVALENCE; VIRUS; WOMEN;
D O I
10.7314/APJCP.2014.15.17.7029
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Certain types of human papillomaviruses (HPVs) are undoubtedly involved in genesis of human malignancies. HPV plays an etiological role in cervical cancer, but also in many vaginal, vulvar, anal and penile cancers, as well as head and neck cancers. In addition, a number of non-malignant diseases such as genital warts and recurrent respiratory papillomatosis are attributable to HPV. Moreover, HPV forms have detected in several other cancers including esophageal squamous cell carcinoma, lung, prostate, ovarian, breast, skin, colorectal and urinary tract cancers, but associations with etiology in these cases is controversial. The aim of this systematic assessment was to estimate the prevalence of HPV infection and HPV types in HPV-associated cancers, HPV-related non-malignant diseases and in cancers that may be associated with HPV in Iran. The present investiagtion covered 61 studies on a variety of cancers in Iranian populations. HPV prevalence was 77.5 % and 32.4% in cervical cancer and head and neck cancers, respectively. HPV was detected in 23.1%, 22.2%, 10.4%, 30.9%, 14% and 25.2% of esophageal squamous cell, lung, prostate, urinary tract cancers, breast and skin cancers, respectively. HPV16 and 18 were the most frequent HPV types in all cancers. The findings of present study imply that current HPV vaccines for cervical cancer may decrease the burden of other cancers if they are really related to HPV.
引用
收藏
页码:7029 / 7035
页数:7
相关论文
共 50 条
  • [21] Human papillomavirus infections in skin cancers
    de Villiers, EM
    BIOMEDICINE & PHARMACOTHERAPY, 1998, 52 (01) : 26 - 33
  • [22] Human papillomavirus in head and neck cancers
    Summersgill, KF
    Smith, EM
    Ritchie, JM
    Haugen, TH
    Turek, LP
    MODERN PATHOLOGY, 2003, 16 (01) : 222A - 222A
  • [23] Human Papillomavirus-Related Cancers
    Li, Yanyun
    Xu, Congjian
    INFECTIOUS AGENTS ASSOCIATED CANCERS: EPIDEMIOLOGY AND MOLECULAR BIOLOGY, 2017, 1018 : 23 - 34
  • [25] The role of human papillomavirus in nongenital cancers
    Zandberg, Dan P.
    Bhargava, Ranjana
    Badin, Simon
    Cullen, Kevin J.
    CA-A CANCER JOURNAL FOR CLINICIANS, 2013, 63 (01) : 57 - 81
  • [26] Cancers attributable to human papillomavirus infection
    Grulich, Andrew E.
    Jin, Fengyi
    Conway, E. Lynne
    Stein, Alicia N.
    Hocking, Jane
    SEXUAL HEALTH, 2010, 7 (03) : 244 - 252
  • [27] Keeping abreast of human papillomavirus in Iran
    Baghi, Hossein Bannazadeh
    Yousefi, Bahman
    Mohammadzadeh, Amir
    Oskouee, Mahin Ahangar
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2018, 27 (06) : 577 - 577
  • [28] Human Papillomavirus in Non-Oropharyngeal Head and Neck Cancers: A Systematic Literature Review
    Isayeva T.
    Li Y.
    Maswahu D.
    Brandwein-Gensler M.
    Head and Neck Pathology, 2012, 6 (Suppl 1) : 104 - 120
  • [29] Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus
    Toh, Zheng Quan
    Kosasih, Jennie
    Russell, Fiona M.
    Garland, Suzanne M.
    Mulholland, Edward K.
    Licciardi, Paul, V
    INFECTION AND DRUG RESISTANCE, 2019, 12 : 1951 - 1967
  • [30] Human Papillomavirus Infection and Related Cancers in Sub-Saharan Africa: Burden and Tools for Prevention Foreword
    Awolude, Olutosin A.
    Morhason-Bello, Imran O.
    Denny, Lynette A.
    Adewole, Isaac F.
    VACCINE, 2013, 31 : VII - X